FindMyKOL

Aakash Desai, MBBS

Enriched profile

Associate Professor · University of Alabama at Birmingham

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Farmington, CT · Northeast · United StatesSpecialtyHematology / OncologyFocusOncology
Active KOLLatest publicationNone indexedOnline presenceNone verifiedPayments2023–2025NIH fundingNone on fileWhy? →

Aakash Desai is Associate Professor at University of Alabama at Birmingham. ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 8 Nov 2026

Overview

Updated 9 Nov 2026

Aakash Desai, MBBS, is Associate Professor at University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 20 companies.

  • Top research focus: Oncology
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 9 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)1 trialSmall Cell Lung Carcinoma1 trial

Research focus

OpenAlex concept fingerprint
Oncology

Drugs & molecules

across trials, industry payments and publications
Rybrevantgeneric · AmivantamabClinical trials—Industry payments11Publications—Libtayogeneric · CemiplimabClinical trials—Industry payments8Publications—Enhertugeneric · TrastuzumabClinical trials—Industry payments4Publications—Tagrissogeneric · OsimertinibClinical trials—Industry payments3Publications—Firdapsegeneric · AmifampridineClinical trials—Industry payments2Publications—Imdelltrageneric · TarlatamabClinical trials—Industry payments2Publications—Imfinzigeneric · DurvalumabClinical trials—Industry payments2Publications—Lumakrasgeneric · SotorasibClinical trials—Industry payments2Publications—Retevmogeneric · SelpercatinibClinical trials—Industry payments2Publications—Braftovigeneric · EncorafenibClinical trials—Industry payments1Publications—Emrelisgeneric · TelisotuzumabClinical trials—Industry payments1Publications—Lorbrenageneric · LorlatinibClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
AstraZeneca Pharmaceuticals LPClinical trials—Industry payments11Janssen Biotech, Inc.Clinical trials—Industry payments8Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments6Abbvie Inc.Clinical trials—Industry payments5Daiichi Sankyo Inc.Clinical trials—Industry payments5Amgen Inc.Clinical trials—Industry payments4Janssen Scientific Affairs, LLCClinical trials—Industry payments4Tempus AI, IncClinical trials—Industry payments4Eli Lilly and CompanyClinical trials—Industry payments3Catalyst Pharmaceuticals, Inc.Clinical trials—Industry payments2E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments2Merck Sharp & Dohme LLCClinical trials—Industry payments2Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments2Array Biopharma IncClinical trials—Industry payments1Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments1Caris MPI, Inc.Clinical trials—Industry payments1Foundation Medicine, Inc.Clinical trials—Industry payments1Genentech USA, Inc.Clinical trials—Industry payments1Life Technologies CorporationClinical trials—Industry payments1Novocure Inc.Clinical trials—Industry payments1University of Alabama at BirminghamClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 8 Nov 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 8 Nov 2026

20 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

All 29 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 8 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    onclive.com/authors/aakash-desai-mbbs-mph

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 8 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.